Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen
- 1 August 1996
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 67 (2) , 157-162
- https://doi.org/10.1016/0301-2115(96)02456-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Continuous Tamoxifen Treatment in Asymptomatic, Postmenopausal Breast Cancer Patients Does Not Cause Aggravation of Endometrial PathologiesGynecologic Oncology, 1994
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1994
- The role of vaginal scan in measurement of endometrial thickness in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleedingAmerican Journal of Obstetrics and Gynecology, 1990
- Long-term adjuvant tamoxifen therapy for breast cancerBreast Cancer Research and Treatment, 1990
- Correlation of ultrasound findings and endometrial histopathology in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.Journal of Clinical Oncology, 1986
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984